SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Helios who wrote (2412)3/28/2000 5:42:00 PM
From: Mike M  Read Replies (2) of 5582
 
In their income statements I see ballooning receivables without an increase in sales, increasing interest expenses (the creditors may end up owning this company before it makes a dime), and a cash burn rate of about a million a quarter, it should be gone by early year if they can't make some money.

That is the problem of analyzing with historical data. There are no creditors. There is no cash burn since 3d qtr 99. $5M in the bank and another $3M at Gel Tech(60% owned by GUMM)....

Sales this quarter will probably result in break even bottom line and positive cash flow.

A product launch with a very large consumer staples company is anticipated next quarter.

Until you ask the CEO why he sold some of his shares you are shooting in the dark on that count.

You can follow Hank's advice if you want but how would you know in which asylum to look for him when you want to kick his silly butt after the short goes sour?

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext